Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Toxicology. 2016 Dec 31;378:17–24. doi: 10.1016/j.tox.2016.12.010

Figure 7. Effect of selected PCDD congeners on CD34 expression.

Figure 7

HSCs (CD34+) were treated with vehicle (VH) (0.02% DMSO) or PCDD congeners (30 nM) on day 0 and co-cultured with HMSCs. The expression of CD34 on HSC-derived HSPCs was measured on day 7 and 14 by flow cytometry. A) The percentage of CD34+ HSPCs. B) The average expression level of CD34 on CD34+ HSPCs, represented by MFI. Data are presented as mean ± SE of triplicate measurements. ***p <0.001, compared to VH by two way ANOVA with Bonferroni posttest. Data are representative of two independent experiments.